Krsmanovic, LZ, Hu, L, Leung, PK, Feng, H, Catt, KJ. The hypothalamic GnRH pulse generator: multiple regulatory mechanisms. Trends Endocrinol Metab. 2009;20(8):402–408.CrossRefGoogle ScholarPubMed

Dufau, ML, Catt, KJ. Gonadotropin receptors and regulation of steroidogenesis in the testis and ovary. Vitam Horm. 1978;36:461–592.Google Scholar

Wahlstrom, T, Huhtaniemi, I, Hovatta, O, Seppala, M. Localization of luteinizing hormone, follicle-stimulating hormone, prolactin, and their receptors in human and rat testis using immunohistochemistry and radioreceptor assay. J Clin Endocrinol Metab. 1983;57(4):825–830.CrossRefGoogle ScholarPubMed

Hayes, FJ, Seminara, SB, Decruz, S, Boepple, PA, Crowley, WF, Jr. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab. 2000;85(9):3027–3035.Google Scholar

Morishima, A, Grumbach, MM, Simpson, ER, Fisher, C, Qin, K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab. 1995;80(12):3689–3698.Google Scholar

Matsumoto, AM, Bremner, WJ. Modulation of pulsatile gonadotropin secretion by testosterone in man. J Clin Endocrinol Metab. 1984;58(4):609–614.Google Scholar

Sheckter, CB, Matsumoto, AM, Bremner, WJ. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary. J Clin Endocrinol Metab. 1989;68(2):397–401.Google Scholar

Anawalt, BD, Bebb, RA, Matsumoto, AM, et al. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab. 1996;81(9):3341–3345.Google ScholarPubMed

O’Connor, AE, De Kretser, DM. Inhibins in normal male physiology. Semin Reprod Med. 2004;22(3):177–185.Google Scholar

Stocco, DM, Clark, BJ. The role of the steroidogenic acute regulatory protein in steroidogenesis. Steroids. 1997;62(1):29–36.Google Scholar

Winters, SJ, Troen, P. Testosterone and estradiol are co-secreted episodically by the human testis. J Clin Invest. 1986;78(4):870–873.Google Scholar

Axelsson, J, Ingre, M, Akerstedt, T, Holmback, U. Effects of acutely displaced sleep on testosterone. J Clin Endocrinol Metab. 2005;90(8):4530–4535.CrossRefGoogle ScholarPubMed

Saez, JM. Leydig cells: endocrine, paracrine, and autocrine regulation. Endocr Rev. 1994;15(5):574–626.Google Scholar

Jarow, JP, Zirkin, BR. The androgen microenvironment of the human testis and hormonal control of spermatogenesis. Ann N Y Acad Sci. 2005;1061:208–220.Google Scholar

Federman, DD. The biology of human sex differences. N Engl J Med. 2006;354(14):1507–1514.Google Scholar

Russell, DW, Wilson, JD. Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem. 1994;63:25–61.Google Scholar

Mahendroo, MS, Mendelson, CR, Simpson, ER. Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem. 1993;268(26):19463–19470.Google Scholar

Dunn, JF, Nisula, BC, Rodbard, D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 1981;53(1):58–68.Google Scholar

Mulhall JP, TL, Brannigan, RE, Kurtz, EG, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200:423–432.CrossRefGoogle ScholarPubMed

Wang, C, Nieschlag, E, Swerdloff, R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl. 2009;30(1):1–9.CrossRefGoogle ScholarPubMed

Emmelot-Vonk, MH, Verhaar, HJ, Nakhai-Pour, HR, Grobbee, DE, van der Schouw, YT. Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males’ Symptoms rating scale (AMS) questionnaires. Clin Endocrinol (Oxf). 2011;74(4):488–494.CrossRefGoogle Scholar

Zitzmann, M. Pharmacogenetics of testosterone replacement therapy. Pharmacogenomics. 2009;10(8):1341–1349.CrossRefGoogle ScholarPubMed

Corona, G, Rastrelli, G, Forti, G, Maggi, M. Update in testosterone therapy for men. J Sex Med. 2011;8(3):639–654; quiz 655.Google Scholar

Diver, MJ, Imtiaz, KE, Ahmad, AM, Vora, JP, Fraser, WD. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf). 2003;58(6):710–717.CrossRefGoogle ScholarPubMed

Wu, FC, Tajar, A, Beynon, JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123–135.CrossRefGoogle ScholarPubMed

Bhasin, S, Pencina, M, Jasuja, GK, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011;96(8):2430–2439.Google Scholar

Vesper, HW, Bhasin, S, Wang, C, et al. Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods. Steroids. 2009;74(6):498–503.CrossRefGoogle ScholarPubMed

Petak, SM, Nankin, HR, Spark, RF, et al. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients – 2002 update. Endocr Pract. 2002;8(6):440–456.Google Scholar

Mulligan, T, Frick, MF, Zuraw, QC, Stemhagen, A, McWhirter, C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762–769.CrossRefGoogle ScholarPubMed

Lewis, RW, Mills, TM. Effect of androgens on penile tissue. Endocrine. 2004;23(2–3):101–105.CrossRefGoogle ScholarPubMed

Morelli, A, Filippi, S, Mancina, R, et al. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology. 2004;145(5):2253–2263.CrossRefGoogle ScholarPubMed

Podlasek, CA, Mulhall, J, Davies, K, et al. Translational perspective on the role of testosterone in sexual function and dysfunction. J Sex Med. 2016;13(8):1183–1198.Google Scholar

Traish, AM, Park, K, Dhir, V, Kim, NN, Moreland, RB, Goldstein, I. Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology. 1999;140(4):1861–1868.Google Scholar

Davila, HH, Rajfer, J, Gonzalez-Cadavid, NF. Corporal veno-occlusive dysfunction in aging rats: evaluation by cavernosometry and cavernosography. Urology. 2004;64(6):1261–1266.Google Scholar

Swaab, DF. Sexual differentiation of the brain and behavior. Best Pract Res Clin Endocrinol Metab. 2007;21(3):431–444.CrossRefGoogle ScholarPubMed

Azad, N, Pitale, S, Barnes, WE, Friedman, N. Testosterone treatment enhances regional brain perfusion in hypogonadal men. J Clin Endocrinol Metab. 2003;88(7):3064–3068.CrossRefGoogle ScholarPubMed

Hoffman, RM, Hunt, WC, Gilliland, FD, Stephenson, RA, Potosky, AL. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma: results from the Prostate Cancer Outcomes Study. Cancer. 2003;97(7):1653–1662.Google Scholar

Potosky, AL, Reeve, BB, Clegg, LX, et al. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst. 2002;94(6):430–437.Google Scholar

Ng, E, Woo, HH, Turner, S, Leong, E, Jackson, M, Spry, N. The influence of testosterone suppression and recovery on sexual function in men with prostate cancer: observations from a prospective study in men undergoing intermittent androgen suppression. J Urol. 2012;187(6):2162–2166.Google Scholar

Corona, G, Isidori, AM, Buvat, J, et al. Testosterone supplementation and sexual function: a meta-analysis study. J Sex Med. 2014;11(6):1577–1592.Google Scholar

Corona, G, Rastrelli, G, Morgentaler, A, Sforza, A, Vannucci, E, Maggi, M. Meta-analysis of results of testosterone therapy on sexual function based on international index of erectile function scores. Eur Urol. 2017;72(6):1000–1011.Google Scholar

Rastrelli, G, Guaraldi, F, Reismann, Y, et al. Testosterone replacement therapy for sexual symptoms. Sex Med Rev. 2019;7(3):464–475.Google Scholar

Maggi, M, Heiselman, D, Knorr, J, Iyengar, S, Paduch, DA, Donatucci, CF. Impact of testosterone solution 2% on ejaculatory dysfunction in hypogonadal men. J Sex Med. 2016;13(8):1220–1226.CrossRefGoogle ScholarPubMed

Nieschlag, E, Nieschlag, S. ENDOCRINE HISTORY: The history of discovery, synthesis and development of testosterone for clinical use. Eur J Endocrinol. 2019;180(6):R201–R212.Google Scholar

Swerdloff, RS, Dudley, RE. A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men. Ther Adv Urol. 2020;12:1756287220937232.Google Scholar

Giagulli, VA, Triggiani, V, Corona, G, et al. Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations. Curr Pharm Des. 2011;17(15):1500–1511.CrossRefGoogle ScholarPubMed

Banks, WA, Morley, JE, Niehoff, ML, Mattern, C. Delivery of testosterone to the brain by intranasal administration: comparison to intravenous testosterone. J Drug Target. 2009;17(2):91–97.Google Scholar

Rogol, AD, Tkachenko, N, Badorrek, P, Hohlfeld, JM, Bryson, N. Phase 1 pharmacokinetics and phase 3 efficacy of testosterone nasal gel in subjects with seasonal allergies. Can Urol Assoc J. 2018;12(7):E349–E356.Google Scholar

Zitzmann, M, Nieschlag, E. Hormone substitution in male hypogonadism. Mol Cell Endocrinol. 2000;161(1–2):73–88.Google Scholar

Wang, C, Harnett, M, Dobs, AS, Swerdloff, RS. Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial. J Androl. 2010;31(5):457–465.CrossRefGoogle ScholarPubMed

Kaminetsky, JC, McCullough, A, Hwang, K, Jaffe, JS, Wang, C, Swerdloff, RS. A 52-week study of dose adjusted subcutaneous testosterone enanthate in oil self-administered via disposable auto-injector. J Urol. 2019;201(3):587–594.Google Scholar

Snyder, PJ, Peachey, H, Berlin, JA, et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab. 2000;85(8):2670–2677.Google Scholar

Bhasin, S, Basaria, S. Diagnosis and treatment of hypogonadism in men. Best Pract Res Clin Endocrinol Metab. 2011;25(2):251–270.Google Scholar

Wang, C, Swerdloff, RS, Iranmanesh, A, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000;85(8):2839–2853.Google Scholar

Carani, C, Scuteri, A, Marrama, P, Bancroft, J. The effects of testosterone administration and visual erotic stimuli on nocturnal penile tumescence in normal men. Horm Behav. 1990;24(3):435–441.Google Scholar

Cunningham, GR, Hirshkowitz, M, Korenman, SG, Karacan, I. Testosterone replacement therapy and sleep-related erections in hypogonadal men. J Clin Endocrinol Metab. 1990;70(3):792–797.Google Scholar

Isidori, AM, Giannetta, E, Greco, EA, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005;63(3):280–293.Google Scholar

Srinivas-Shankar, U, Roberts, SA, Connolly, MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2010;95(2):639–650.Google Scholar

Basaria, S, Coviello, AD, Travison, TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109–122.Google Scholar

Zarrouf, FA, Artz, S, Griffith, J, Sirbu, C, Kommor, M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract. 2009;15(4):289–305.CrossRefGoogle ScholarPubMed

Cunningham, GR, Toma, SM. Clinical review: Why is androgen replacement in males controversial? J Clin Endocrinol Metab. 2011;96(1):38–52.Google Scholar

Sih, R, Morley, JE, Kaiser, FE, Perry, HM, 3rd, Patrick, P, Ross, C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997;82(6):1661–1667.Google Scholar

Coviello, AD, Kaplan, B, Lakshman, KM, Chen, T, Singh, AB, Bhasin, S. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab. 2008;93(3):914–919.Google Scholar

Hanafy, HM. Testosterone therapy and obstructive sleep apnea: is there a real connection? J Sex Med. 2007;4(5):1241–1246.Google Scholar

Guay, AT, Jacobson, J, Perez, JB, Hodge, MB, Velasquez, E. Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit? Int J Impot Res. 2003;15(3):156–165.Google Scholar

Katz, DJ, Nabulsi, O, Tal, R, Mulhall, JP. Outcomes of clomiphene citrate treatment in young hypogonadal men. BJU Int. 2012;110(4):573–578.CrossRefGoogle ScholarPubMed

Krzastek, SC, Sharma, D, Abdullah, N, et al. Long-term safety and efficacy of clomiphene citrate for the treatment of hypogonadism. J Urol. 2019;202(5):1029–1035.Google Scholar

Wheeler, KM, Sharma, D, Kavoussi, PK, Smith, RP, Costabile, R. Clomiphene citrate for the treatment of hypogonadism. Sex Med Rev. 2019;7(2):272–276.Google Scholar

Delemarre, EM, Felius, B, Delemarre-van de Waal, HA. Inducing puberty. Eur J Endocrinol. 2008;159(Suppl. 1):S9–S15.Google Scholar

Buchter, D, Behre, HM, Kliesch, S, Nieschlag, E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998;139(3):298–303.Google Scholar

Raman, JD, Schlegel, PN. Aromatase inhibitors for male infertility. J Urol. 2002;167(2 Pt 1):624–629.Google Scholar

Dadhich, P, Ramasamy, R, Scovell, J, Wilken, N, Lipshultz, L. Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men. Indian J Urol. 2017;33(3):236–240.Google Scholar

Ramasamy, R, Masterson, TA, Best, JC, et al. Effect of Natesto on reproductive hormones, semen parameters and hypogonadal symptoms: a single center, open label, single arm trial. J Urol. 2020;204(3):557–563.Google Scholar

Kavoussi, PK MG, Gilkey, M, Hunn, C, et al. Converting men from clomiphene citrate to Natesto for hypogonadism improves libido, maintains semen parameters, and reduces estradiol. Urology. 2021;148:141–144.Google Scholar

Tanrikut, C, Goldstein, M, Rosoff, JS, Lee, RK, Nelson, CJ, Mulhall, JP. Varicocele as a risk factor for androgen deficiency and effect of repair. BJU Int. 2011;108(9):1480–1484.Google Scholar

Li, F, Yue, H, Yamaguchi, K, et al. Effect of surgical repair on testosterone production in infertile men with varicocele: a meta-analysis. Int J Urol. 2012;19(2):149–154.Google Scholar

Chen, X, Yang, D, Lin, G, Bao, J, Wang, J, Tan, W. Efficacy of varicocelectomy in the treatment of hypogonadism in subfertile males with clinical varicocele: a meta-analysis. Andrologia. 2017;49(10):e12778. https://doi.org/10.1111/and.12778.Google Scholar

Ahmed, AF, Abdel-Aziz, AS, Maarouf, AM, Ali, M, Emara, AA, Gomaa, A. Impact of varicocelectomy on premature ejaculation in varicocele patients. Andrologia. 2015;47(3):276–281.Google Scholar

Abdel-Meguid, TA, Farsi, HM, Al-Sayyad, A, Tayib, A, Mosli, HA, Halawani, AH. Effects of varicocele on serum testosterone and changes of testosterone after varicocelectomy: a prospective controlled study. Urology. 2014;84(5):1081–1087.CrossRefGoogle ScholarPubMed

Zohdy, W, Ghazi, S, Arafa, M. Impact of varicocelectomy on gonadal and erectile functions in men with hypogonadism and infertility. J Sex Med. 2011;8(3):885–893.Google Scholar

Najari, BB, Introna, L, Paduch, DA. Improvements in patient-reported sexual function after microsurgical varicocelectomy. Urology. 2017;110:104–109.Google Scholar

Huggins, C. Effect of orchiectomy and irradiation on cancer of the prostate. Ann Surg. 1942;115(6):1192–1200.Google Scholar

Morgentaler, A, Traish, A. The history of testosterone and the evolution of its therapeutic potential. Sex Med Rev. 2020;8(2):286–296.Google Scholar

Roddam, AW, Allen, NE, Appleby, P, Key, TJ. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst. 2008;100(3):170–183.Google Scholar

Marks, LS, Mazer, NA, Mostaghel, E, et al. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA. 2006;296(19):2351–2361.Google Scholar

Khera, M, Bhattacharya, RK, Blick, G, Kushner, H, Nguyen, D, Miner, MM. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory. J Urol. 2011;186(3):1005–1011.Google Scholar

Davidson, E, Morgentaler, A. Testosterone therapy and prostate cancer. Urol Clin North Am. 2016;43(2):209–216.Google Scholar

Morgentaler, A, Traish, AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol. 2009;55(2):310–320.Google Scholar

Wallis, CJ, Lo, K, Lee, Y, et al. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study. Lancet Diabetes Endocrinol. 2016;4(6):498–506.Google Scholar

Thompson, IM, Pauler, DK, Goodman, PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004;350(22):2239–2246.Google Scholar

Salonia, A, Abdollah, F, Capitanio, U, et al. Serum sex steroids depict a nonlinear u-shaped association with high-risk prostate cancer at radical prostatectomy. Clin Cancer Res. 2012;18(13):3648–3657.CrossRefGoogle ScholarPubMed

San Francisco, IF, Rojas, PA, DeWolf, WC, Morgentaler, A. Low free testosterone levels predict disease reclassification in men with prostate cancer undergoing active surveillance. BJU Int. 2014;114(2):229–235.Google Scholar

Leon, P, Seisen, T, Cussenot, O, et al. Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer. Urol Oncol. 2015;33(9):384.e21–27.Google Scholar

Ahlering, TE, My Huynh, L, Towe, M, et al. Testosterone replacement therapy reduces biochemical recurrence after radical prostatectomy. BJU Int. 2020;126(1):91–96.Google Scholar

Sarosdy, MF. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Cancer. 2007;109(3):536–541.Google Scholar

Balbontin, FG, Moreno, SA, Bley, E, Chacon, R, Silva, A, Morgentaler, A. Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer. BJU Int. 2014;114(1):125–130.Google Scholar

Pastuszak, AW, Khanna, A, Badhiwala, N, et al. Testosterone therapy after radiation therapy for low, intermediate and high risk prostate cancer. J Urol. 2015;194(5):1271–1276.Google Scholar

Kacker, R, Hult, M, San Francisco, IF, et al. Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results. Asian J Androl. 2016;18(1):16–20.CrossRefGoogle ScholarPubMed

Morgentaler, A, Lipshultz, LI, Bennett, R, Sweeney, M, Avila, D, Jr., Khera, M. Testosterone therapy in men with untreated prostate cancer. J Urol. 2011;185(4):1256–1260.Google Scholar

Debruyne, FM, Behre, HM, Roehrborn, CG, et al. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men. BJU Int. 2017;119(2):216–224.Google Scholar

Kohn, TP, Mata, DA, Ramasamy, R, Lipshultz, LI. Effects of testosterone replacement therapy on lower urinary tract symptoms: a systematic review and meta-analysis. Eur Urol. 2016;69(6):1083–1090.Google Scholar

Yabe, S, Kato, H, Mizukawa, S, et al. Predictive factors for outcomes of patients undergoing endoscopic therapy for bile leak after hepatobiliary surgery. Dig Endosc. 2017;29(3):353–361.Google Scholar

LeBrasseur, NK, Lajevardi, N, Miciek, R, Mazer, N, Storer, TW, Bhasin, S. Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (the TOM trial): design and methods. Contemp Clin Trials. 2009;30(2):133–140.Google Scholar

Vigen, R, O’Donnell, CI, Baron, AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310(17):1829–1836.Google Scholar

Traish, AM, Guay, AT, Morgentaler, A. Death by testosterone? We think not! J Sex Med. 2014;11(3):624–629.Google Scholar

Ho, PM, Baron, AE, Wierman, ME. Deaths and cardiovascular events in men receiving testosterone: reply. JAMA. 2014;311(9):964–965.Google Scholar

Finkle, WD, Greenland, S, Ridgeway, GK, et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS ONE. 2014;9(1):e85805.CrossRefGoogle ScholarPubMed

Morgentaler, A, Miner, MM, Caliber, M, Guay, AT, Khera, M, Traish, AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015;90(2):224–251.Google Scholar

Ohlsson, C, Barrett-Connor, E, Bhasin, S, et al. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol. 2011;58(16):1674–1681.CrossRefGoogle ScholarPubMed

Araujo, AB, Dixon, JM, Suarez, EA, Murad, MH, Guey, LT, Wittert, GA. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(10):3007–3019.Google Scholar

Bojesen, A, Juul, S, Gravholt, CH. Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab. 2003;88(2):622–626.Google Scholar

Fruhmesser, A, Kotzot, D. Chromosomal variants in Klinefelter syndrome. Sex Dev. 2011;5(3):109–123.Google Scholar

Hotaling, JM. Genetics of male infertility. Urol Clin North Am. 2014;41(1):1–17.Google Scholar

Ross, A, Bhasin, S. Hypogonadism: its prevalence and diagnosis. Urol Clin North Am. 2016;43(2):163–176.Google Scholar

Loebenstein, M, Thorup, J, Cortes, D, Clasen-Linde, E, Hutson, JM, Li, R. Cryptorchidism, gonocyte development, and the risks of germ cell malignancy and infertility: a systematic review. J Pediatr Surg. 2020;55(7):1201–1210.Google Scholar

Rochira, V, Diazzi, C, Santi, D, et al. Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study. Andrology. 2015;3(2):298–308.CrossRefGoogle ScholarPubMed

Zaid, MIA, Menendez, AG, Charif, OE, et al. Adverse health outcomes in relationship to hypogonadism (HG) after platinum-based chemotherapy: a multicenter study of North American testicular cancer survivors (TCS). J Clin Oncol. 2017;35(18_suppl):LBA10012–LBA10012.Google Scholar

Dode, C, Hardelin, JP. Kallmann syndrome. Eur J Hum Genet. 2009;17(2):139–146.Google Scholar

Fechner, A, Fong, S, McGovern, P. A review of Kallmann syndrome: genetics, pathophysiology, and clinical management. Obstet Gynecol Surv. 2008;63(3):189–194.Google Scholar

Hardelin, JP, Dode, C. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev. 2008;2(4–5):181–193.Google Scholar

Smeets, DF, Hamel, BC, Nelen, MR, et al. Prader-Willi syndrome and Angelman syndrome in cousins from a family with a translocation between chromosomes 6 and 15. N Engl J Med. 1992;326(12):807–811.CrossRefGoogle ScholarPubMed

de Vries, F, Bruin, M, Lobatto, DJ, et al. Opioids and their endocrine effects: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2020;105(4):1020–1029.CrossRefGoogle ScholarPubMed

Rasmussen, JJ, Selmer, C, Ostergren, PB, et al. Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study. PLoS ONE. 2016;11(8):e0161208.Google Scholar

Buvat, J. Hyperprolactinemia and sexual function in men: a short review. Int J Impot Res. 2003;15(5):373–377.Google Scholar

Carter, JN, Tyson, JE, Tolis, G, Van Vliet, S, Faiman, C, Friesen, HG. Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med. 1978;299(16):847–852.Google Scholar

Patel, SS, Bamigboye, V. Hyperprolactinaemia. J Obstet Gynaecol. 2007;27(5):455–459.Google Scholar

Corona, G, Monami, M, Rastrelli, G, et al. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2011;8(1):272–283.Google Scholar

Wu, FC, Tajar, A, Pye, SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93(7):2737–2745.Google Scholar

Feldman, HA, Longcope, C, Derby, CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87(2):589–598.CrossRefGoogle ScholarPubMed

Fink, HA, Ewing, SK, Ensrud, KE, et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab. 2006;91(10):3908–3915.Google Scholar

Diem, SJ, Greer, NL, MacDonald, R, et al. Efficacy and safety of testosterone treatment in men: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2020;172(2):105–118.Google Scholar

Lu, NZ, Wardell, SE, Burnstein, KL, et al. International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev. 2006;58(4):782–797.Google Scholar

Mooradian, AD, Morley, JE, Korenman, SG. Biological actions of androgens. Endocr Rev. 1987;8(1):1–28.Google Scholar

Narayanan, R, Coss, CC, Dalton, JT. Development of selective androgen receptor modulators (SARMs). Mol Cell Endocrinol. 2018;465:134–142.Google Scholar

Bhasin, S, Cunningham, GR, Hayes, FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536–2559.Google Scholar

Solomon, ZJ, Mirabal, JR, Mazur, DJ, et al. Selective androgen receptor modulators: current knowledge and clinical applications. Sex Med Rev. 2019;7(1):84–94.CrossRefGoogle ScholarPubMed

Mulhall, JP, Trost, LW, Brannigan, RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423–432.Google Scholar

Burns, KA, Korach, KS. Estrogen receptors and human disease: an update. Arch Toxicol. 2012;86(10):1491–1504.Google Scholar

Dhandapani, KM, Brann, DW. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod. 2002;67(5):1379–1385.Google Scholar

Rodan, GA, Martin, TJ. Therapeutic approaches to bone diseases. Science. 2000;289(5484):1508–1514.Google Scholar

Charles, D, Barr, W, Bell, ET, Brown, JB, Fotherby, K, Loraine, JA. Clomiphene in the treatment of oligomenorrhea and amenorrhea. Am J Obstet Gynecol. 1963;86:913–922.Google Scholar

Zhang, X, Lanter, JC Sui, Z. Recent advances in the development of selective androgen receptor modulators. Expert Opin Ther Pat. 2009;19(9):1239–1258.Google Scholar

Dalton, JT, Mukherjee, A, Zhu, Z, Kirkovsky, L, Miller, DD. Discovery of nonsteroidal androgens. Biochem Biophys Res Commun. 1998;244(1):1–4.Google Scholar

Link, JT, Sorensen, B, Patel, J, et al. Antidiabetic activity of passive nonsteroidal glucocorticoid receptor modulators. J Med Chem. 2005:48(16):5295–5304.Google Scholar

Tabata, Y, Iizuka, Y, Shinei, R, et al. CP8668, a novel orally active nonsteroidal progesterone receptor modulator with tetrahydrobenzindolone skeleton. Eur J Pharmacol. 2003;461(1):73–78.Google Scholar

Gao, W, Reiser, PJ, Coss, CC, et al. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. Endocrinology. 2005;146(11):4887–4897.Google Scholar

Yin, D, He, Y, Perera, MA, et al. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Mol Pharmacol. 2003;63(1):211–223.Google Scholar

Srinath, R, Dobs, A. Enobosarm (GTx-024, S-22): a potential treatment for cachexia. Future Oncol. 2014;10(2):187–194.Google Scholar

Crawford, J, Prado, CMM, Johnston, MA, et al. Study design and rationale for the phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER Trials). Curr Oncol Rep. 2016;18(6):37.Google Scholar

Dalton, JT, Barnette, KG, Bohl, CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011;2(3):153–161.Google Scholar

Dobs, AS, Boccia, RV, Croot, CC, et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol. 2013;14(4):335–345.Google Scholar

Kearbey, JD, Gao, W, Narayanan, R, et al. Selective androgen receptor modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharm Res. 2007;24(2):328–335.Google Scholar

Jones, A, Hwang, DJ, Duke, CD 3rd, et al. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation. J Pharmacol Exp Ther. 2010;334(2):439–448.CrossRefGoogle ScholarPubMed

Miner, JN, Chang, W, Chapman, MS, et al. An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate. Endocrinology. 2007;148(1):363–373.Google Scholar

Chisamore, MJ, Gentile, MA, Dillon, GM, et al. A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice. J Steroid Biochem Mol Biol. 2016;163:88–97.Google Scholar

Dubois, V, Simitsidellis, I, Laurent, MR, et al. Enobosarm (GTx-024) modulates adult skeletal muscle mass independently of the androgen receptor in the satellite cell lineage. Endocrinology. 2015;156(12):4522–4533.Google Scholar

Morimoto, M, Yamaoka, M, Hara, T. A selective androgen receptor modulator SARM-2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys. Pharmacol Res Perspect. 2020;8(1):e00563.Google Scholar

Neil, D, Clark, RV, Magee, M, et al. GSK2881078, a SARM, produces dose-dependent increases in lean mass in healthy older men and women. J Clin Endocrinol Metab. 2018;103(9):3215–3224.Google Scholar

GTx reports results for enobosarm POWER trials for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer. Businesswire. April 16, 2020. Available from: www.businesswire.com/news/home/20130819005378/en/GTx-Reports-Results-Enobosarm-POWER-Trials-Prevention. Accessed November 10, 2022.Google Scholar

Papanicolaou, DA, Ather, SN, Zhu, H, et al. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. J Nutr Health Aging. 2013;17(6):533–543.Google Scholar

Bhasin, S. Selective androgen receptor modulators as function promoting therapies. J Frailty Aging. 2015;4(3):121–122.Google Scholar

Nejishima, H, Yamamoto, N, Suzuki, M, Furuya, K, Nagata, N, Yamada, S. Anti-androgenic effects of S-40542, a novel non-steroidal selective androgen receptor modulator (SARM) for the treatment of benign prostatic hyperplasia. Prostate. 2012;72(14):1580–1587.Google Scholar

Gao, W, Kearby, JD, Nair, VA, et al. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia. Endocrinology. 2004;145(12):5420–5428.Google Scholar

OPKO provides update on the development of OPK-88004, a selective androgen receptor modulator. OPKO. April 16, 2020. Available from: www.opko.com/news-media/press-releases/detail/351/opko-provides-update-on-the-development-of-opk-88004-a. Accessed November 10, 2022.Google Scholar

Chen, J, Hwang, DJ, Bohl, CE, Miller, DD, Dalton, JT. A selective androgen receptor modulator for hormonal male contraception. J Pharmacol Exp Ther. 2005;312(2):546–553.Google Scholar

Jones, A, Chen, J, Hwang, DJ, Miller, DD, Dalton, JT. Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception. Endocrinology. 2009;150(1):385–395.Google Scholar

Thirumalai, A, Berkseth, KE, Amory, JK. Treatment of hypogonadism: current and future therapies. F1000Res. 2017;6:68.Google Scholar

Vignozzi, L, Morelli, A, Sarchielli, E, et al. Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit. J Endocrinol. 2012;212(1):71–84.Google Scholar

Choi, SM, Lee, BM. Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids. Expert Opin Drug Saf. 2015;14(11):1773–1785.Google Scholar

Bhattacharya, I, Tarabar, S, Liang, Y, Pradhan, V, Owens, J, Oemar, B. Safety, pharmacokinetic, and pharmacodynamic evaluation after single and multiple ascending doses of a novel selective androgen receptor modulator in healthy subjects. Clin Ther. 2016;38(6):1401–1416.Google Scholar

Clark, RV, Walker, AC, Andrews, S, et al. Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women. Br J Clin Pharmacol. 2017;83(10):2179–2194.Google Scholar

Thevis, M, Geyer, H, Kamber, M, Schänzer, W. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. Drug Test Anal. 2009;1(8):387–392.Google Scholar

Westerman, ME, Charchenko, CM, Ziegelmann, MJ, Bailey, GC, Nippoldt, TB, Trost, L. Heavy testosterone use among bodybuilders: an uncommon cohort of illicit substance users. Mayo Clin Proc. 2016;91(2):175–182.CrossRefGoogle ScholarPubMed

Van Wagoner, RM, Eichner, A, Bhasin, S, et al. Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the internet. JAMA. 2017;318(20):2004–2010.Google Scholar

Mulhall, JP, Trost, LW, Brannigan, RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423–432. doi:10.1016/j.juro.2018.03.115Google Scholar

Harman, SM, Metter, EJ, Tobin, JD, Pearson, J, Blackman, MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86(2):724–731. doi:10.1210/jcem.86.2.7219Google Scholar

Howden, LM, Meyer, JA. 2010 Census Brief: Age and Sex Composition. 2011. www.census.gov/population. Accessed March 16, 2020.Google Scholar

US Census. Population QuickFacts. 2019. www.census.gov/quickfacts/fact/table/US/LFE046218. Published 2020. Accessed July 19, 2020.Google Scholar

Cohen, J, Nassau, DE, Patel, P, Ramasamy, R. Low testosterone in adolescents & young adults. Front Endocrinol (Lausanne). 2020;10. doi:10.3389/fendo.2019.00916Google Scholar

Martin, JA, Brady, MPH, Hamilton, E, Osterman, MJK, Driscoll, AK, Mathews, TJ. Births final data for 2015. Natl Vital Stat Rep. 2017;66(1):1. www.cdc.gov/nchs/data_access/Vitalstatsonline.htm. Accessed March 16, 2020.Google Scholar

Basaria, S. Male hypogonadism. Lancet. 2014;383(9924):1250–1263. doi:10.1016/S0140-6736(13)61126-5Google Scholar

Roth, MY, Page, ST, Lin, K, et al. Dose-dependent increase in intratesticular testosterone by very low-dose human chorionic gonadotropin in normal men with experimental gonadotropin deficiency. J Clin Endocrinol Metab. 2010;95(8):3806–3813. doi:10.1210/jc.2010-0360Google Scholar

Walker, WH. Non-classical actions of testosterone and spermatogenesis. Philos Trans R Soc Lond B Biol Sci. 2010;365(1546):1557–1569. doi:10.1098/rstb.2009.0258Google Scholar

Patel, AS, Leong, JY, Ramos, L, Ramasamy, R. Testosterone is a contraceptive and should not be used in men who desire fertility. World J Mens Health. 2019;37(1):45–54. doi:10.5534/wjmh.180036Google Scholar

World Health Organisation Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet. 1990;336(8721):955–959. doi:10.1016/0140-6736(90)92416-FGoogle Scholar

Baillargeon, J, Kuo, Y-F, Westra, JR, Urban, RJ, Goodwin, JS. Testosterone prescribing in the United States, 2002–2016. JAMA. 2018;320(2):200–202. doi:10.1001/jama.2018.7999Google Scholar

Baillargeon, J, Urban, RJ, Ottenbacher, KJ, Pierson, KS, Goodwin, JS. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med. 2013;173(15):1465–1466. doi:10.1001/jamainternmed.2013.6895Google Scholar

Kansal, JK, Dietrich, PN, Doolittle, J, et al. MP45–17: online marketing practices and characteristics of stand-alone men’s health clinics. J Urol. 2020;203(4):e671. doi:10.1097/JU.0000000000000900.017Google Scholar

Dotson, JL, Brown, RT. The history of the development of anabolic-androgenic steroids. Pediatr Clin North Am. 2007;54(4):761–769. doi:10.1016/j.pcl.2007.04.003Google Scholar

Tatem, AJ, Beilan, J, Kovac, JR, Lipshultz, LI. Management of anabolic steroid-induced infertility: novel strategies for fertility maintenance and recovery. World J Mens Health. 2020;38(2):141–150. doi:10.5534/wjmh.190002Google Scholar

Silver, MD. Use of ergogenic aids by athletes. J Am Acad Orthop Surg. 2001;9(1):61–70. doi:10.5435/00124635-200101000-00007Google Scholar

Kanayama, G, Pope, HG. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 2018;464:4–13. doi:10.1016/j.mce.2017.02.039Google Scholar

Coward, RM, Rajanahally, S, Kovac, JR, Smith, RP, Pastuszak, AW, Lipshultz, LI. Anabolic steroid induced hypogonadism in young men. J Urol. 2013;190(6):2200–2205. doi:10.1016/j.juro.2013.06.010Google Scholar

Ly, LP, Liu, PY, Handelsman, DJ. Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens. Hum Reprod. 2005;20(6):1733–1740. doi:10.1093/humrep/deh834Google Scholar

Kohn, TP, Louis, MR, Pickett, SM, et al. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertil Steril. 2017;107(2):351–357.e1. doi:10.1016/j.fertnstert.2016.10.004Google Scholar

Rahnema, CD, Lipshultz, LI, Crosnoe, LE, Kovac, JR, Kim, ED. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014;101:1271–1279. doi:10.1016/j.fertnstert.2014.02.002Google Scholar

Wenker, EP, Dupree, JM, Langille, GM, et al. The use of HCG-based combination therapy for recovery of spermatogenesis after testosterone use. J Sex Med. 2015;12(6):1334–1337. doi:10.1111/jsm.12890Google Scholar

Chambers, T, Anderson, R. The impact of obesity on male fertility. Hormones. 2015;14(4):563–568. doi:10.14310/horm.2002.1621Google Scholar

Grossmann, M. Hypogonadism and male obesity: focus on unresolved questions. Clin Endocrinol (Oxf). 2018;89(1):11–21. doi:10.1111/cen.13723Google Scholar

Ng Tang Fui, M, Prendergast, LA, Dupuis, P, et al. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial. BMC Med. 2016;14(1):153. doi:10.1186/s12916-016-0700-9Google Scholar

Rigon, FA, Ronsoni, MF, Hohl, A, van de Sande-Lee, S. Effects of bariatric surgery in male obesity-associated hypogonadism. Obes Surg. 2019;29(7):2115–2125. doi:10.1007/s11695-019-03829-0Google Scholar

Krzastek, SC, Smith, RP. Non-testosterone management of male hypogonadism: an examination of the existing literature. Transl Androl Urol. 2020;9(S2):S160–S170. doi:10.21037/tau.2019.11.16Google Scholar

Wheeler, KM, Sharma, D, Kavoussi, PK, Smith, RP, Costabile, R. Clomiphene citrate for the treatment of hypogonadism. Sex Med Rev. 2019;7(2):272–276. doi:10.1016/j.sxmr.2018.10.001Google Scholar

Whitten, SJ, Nangia, AK, Kolettis, PN. Select patients with hypogonadotropic hypogonadism may respond to treatment with clomiphene citrate. Fertil Steril. 2006;86(6):1664–1668. doi:10.1016/j.fertnstert.2006.05.042Google Scholar

Pasqualotto, FF, Fonseca, GP, Pasqualotto, EB. Azoospermia after treatment with clomiphene citrate in patients with oligospermia. Fertil Steril. 2008;90(5):2014.e11–2014.e12. doi:10.1016/j.fertnstert.2008.03.036Google Scholar

Pavlovich, CP, King, P, Goldstein, M, Schlegel, PN. Evidence of a treatable endocrinopathy in infertile men. J Urol. 2001;165(3):837–841. www.ncbi.nlm.nih.gov/pubmed/11176482.Google Scholar

Raman, JD, Schlegel, PN. Aromatase inhibitors for male infertility. J Urol. 2002;98(6):624–629. doi:10.1097/00005392-200202000-00038Google Scholar

Coviello, AD, Matsumoto, AM, Bremner, WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90(5):2595–2602. doi:10.1210/jc.2004-0802Google Scholar

Turek, PJ, Williams, RH, Gilbaugh, JHI, Lipshultz, LI. The reversibility of anabolic steroid-induced azoospermia. J Urol. 1995;153(5):1628–1630. doi:10.1016/S0022-5347(01)67482-2Google Scholar

McBride, JA, Coward, R. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use. Asian J Androl. 2016;18(3):373–380. doi:10.4103/1008-682X.173938Google Scholar

Buchter, D, Behre, H, Kliesch, S, Nieschlag, E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998;139(3):298–303. doi:10.1530/eje.0.1390298Google Scholar

Burgues, S, Calderon, MD. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Hum Reprod. 1997;12(5):980–986. doi:10.1093/humrep/12.5.980Google Scholar

Bhasin, S, Brito, JP, Cunningham, GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229Google Scholar

Hsieh, T-C, Pastuszak, AW, Hwang, K, Lipshultz, LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189:647–650. doi:10.1016/j.juro.2012.09.043Google Scholar

Lee, JA, Ramasamy, R. Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men. Transl Androl Urol. 2018;7(Suppl. 3):S348–S352. doi:10.21037/tau.2018.04.11Google Scholar

Ramasamy, R, Armstrong, J, Lipshultz, L. Preserving fertility in the hypogonadal patient: an update. Asian J Androl. 2015;17(2):197–200. doi:10.4103/1008-682X.142772Google Scholar

Liu, PY, Turner, L, Rushford, D, et al. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Hum Reprod. 1999;14(6):1540–1545. doi:10.1093/humrep/14.6.1540.Google Scholar

Ishikawa, T, Ooba, T, Kondo, Y, Yamaguchi, K, Fujisawa, M. Assessment of gonadotropin therapy in male hypogonadotropic hypogonadism. Fertil Steril. 2007;88(6):1697–1699. doi:10.1016/j.fertnstert.2006.11.022Google Scholar

Patel, A, Patel, P, Bitran, J, Ramasamy, R. Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? Transl Androl Urol. 2019;8(S1):S58–S63. doi:10.21037/tau.2019.01.16Google Scholar

Amory, JK, Coviello, AD, Page, ST, Anawalt, BD, Matsumoto, AM, Bremner, WJ. Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin. Fertil Steril. 2008;89(2):380–386. doi:10.1016/j.fertnstert.2007.02.059Google Scholar

Ramasamy, R, Masterson, TA, Best, JC, et al. Effect of Natesto on reproductive hormones, semen parameters and hypogonadal symptoms: a single center, open label, single arm trial. J Urol. 2020;204(3):557–563. doi:10.1097/JU.0000000000001078Google Scholar

Arora, H, Zuttion, MSSR, Nahar, B, Lamb, D, Hare, JM, Ramasamy, R. Subcutaneous Leydig stem cell autograft: a promising strategy to increase serum testosterone. Stem Cells Transl Med. 2019;8(1):58–65. doi:10.1002/sctm.18-0069Google Scholar

Fayomi, AP, Peters, K, Sukhwani, M, et al. Autologous grafting of cryopreserved prepubertal rhesus testis produces sperm and offspring. Science. 2019;363(6433):1314–1319. doi:10.1126/science.aav2914Google Scholar

Krueger, JM, Frank, MG, Wisor, JP, Roy, S. Sleep function: toward elucidating an enigma. Sleep Med Rev. 2016;28:46–54. doi:10.1016/j.smrv.2015.08.005.Google Scholar

Centers for Disease Control and Prevention. Short sleep duration among US adults. www.cdc.gov/sleep/data_statistics.html. Updated 2017. Accessed June 26, 2020.Google Scholar

Watson, NF, Badr, MS, Belenky, G, et al. Joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society on the recommended amount of sleep for a healthy adult: methodology and discussion. J Clin Sleep Med. 2015;11(8):931–952. doi:10.5664/jcsm.4950.Google Scholar

Luyster, FS, Strollo, PJ, Zee, PC, Walsh, JK. Sleep: a health imperative. Sleep. 2012;35(6):727–734. doi:10.5665/sleep.1846.Google Scholar

McMenamin, TM. A time to work: recent trends in shift work and flexible schedules. Mon Labor Rev. 2007;130(12):3–15. www.scopus.com/inward/record.uri?eid=2-s2.0-39749201717&partnerID=40&md5=394413e24b44176f8bcdb03b6e58a218. Accessed June 27, 2020.Google Scholar

Åkerstedt, T, Wright, KP. Sleep loss and fatigue in shift work and shift work disorder. Sleep Med Clin. 2009;4(2):257–271. doi: 10.1016/j.jsmc.2009.03.001.Google Scholar

Sateia, MJ. International classification of sleep disorders – third edition. Chest. 2014;146(5):1387–1394. doi:10.1378/chest.14-0970.Google Scholar

Drake, CL, Roehrs, T, Richardson, G, Walsh, JK, Roth, T. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep. 2004;27(8):1453–1462. doi:10.1093/sleep/27.8.1453.Google Scholar

Vanttola, P, Puttonen, S, Karhula, K, Oksanen, T, Härmä, M. Prevalence of shift work disorder among hospital personnel: a cross-sectional study using objective working hour data. J Sleep Res. 2019;29(3):e12906. doi:10.1111/jsr.12906.Google Scholar

Fekedulegn, D, Burchfiel, CM, Hartley, TA, et al. Shiftwork and sickness absence among police officers: the BCOPS study. Chronobiol Int. 2013;30(7):930–941. doi:10.3109/07420528.2013.790043.Google Scholar

Nätti, J, Oinas, T, Härmä, M, Anttila, T, Kandolin, I. Combined effects of shiftwork and individual working time control on long-term sickness absence: a prospective study of Finnish employees. J Occup Environ Med. 2014;56(7):732–738. doi:10.1097/JOM.0000000000000176.Google Scholar

Lockley, SW, Barger, LK, Ayas, NT, Rothschild, JM, Czeisler, CA, Landrigan, CP. Effects of health care provider work hours and sleep deprivation on safety and performance. Jt Comm J Qual Patient Saf. 2007;33(Suppl. 11):7–18. doi:10.1016/S1553-7250(07)33109-7.Google ScholarPubMed

Keller, SM. Effects of extended work shifts and shift work on patient safety, productivity, and employee health. AAOHN J. 2009;57(12):497–504. doi:10.3928/08910162-20091116-01.Google Scholar

Garbarino, S, De Carli, F, Nobili, L, et al. Sleepiness and sleep disorders in shift workers: a study on a group of Italian police officers. Sleep. 2002;25(6):648–653. www.scopus.com/inward/record.uri?eid=2-s2.0-0037105031&partnerID=40&md5=ab041b7db1a8e5f30a104d7b96fe1b49. Accessed June 27, 2020.Google Scholar

Gan, Y, Yang, C, Tong, X, et al. Shift work and diabetes mellitus: a meta-analysis of observational studies. Occup Environ Med. 2015;72(1):72–78. doi:10.1136/oemed-2014-102150.Google Scholar

Ika, K, Suzuki, E, Mitsuhashi, T, Takao, S, Doi, H. Shift work and diabetes mellitus among male workers in Japan: does the intensity of shift work matter? Acta Med Okayama. 2013;67(1):25–33. doi:10.18926/AMO/49254.Google Scholar

Hansen, AB, Stayner, L, Hansen, J, Andersen, ZJ. Night shift work and incidence of diabetes in the Danish nurse cohort. Occup Environ Med. 2016;73(4):262–268. doi:10.1136/oemed-2015-103342.Google Scholar

Alefishat, E, Abu Farha, R. Is shift work associated with lipid disturbances and increased insulin resistance? Metab Syndr Relat Disord. 2015;13(9):400–405. doi:10.1089/met.2015.0052.Google Scholar

Kawachi, I, Colditz, GA, Stampfer, MJ, et al. Prospective study of shift work and risk of coronary heart disease in women. Circulation. 1995;92(11):3178–3182. doi:10.1161/01.CIR.92.11.3178.Google Scholar

Vetter, C, Devore, EE, Wegrzyn, LR, et al. Association between rotating night shift work and risk of coronary heart disease among women. JAMA. 2016;315(16):1726–1734. doi:10.1001/jama.2016.4454.Google Scholar

Ceïde, ME, Pandey, A, Ravenell, J, Donat, M, Ogedegbe, G, Girardin, JL. Associations of short sleep and shift work status with hypertension among black and white Americans. Int J Hypertens. 2015;2015:697275. doi:10.1155/2015/697275.Google Scholar

Ohlander, J, Keskin, M, Stork, J, Radon, K. Shift work and hypertension: prevalence and analysis of disease pathways in a German car manufacturing company. Am J Ind Med. 2015;58(5):549–560. doi:10.1002/ajim.22437.Google Scholar

Guo, Y, Liu, Y, Huang, X, et al. The effects of shift work on sleeping quality, hypertension and diabetes in retired workers. PLoS ONE. 2013;8(8):e71107. doi:10.1371/journal.pone.0071107.Google Scholar

Lee, HY, Kim, MS, Kim, O, Lee, I, Kim, H. Association between shift work and severity of depressive symptoms among female nurses: the Korea nurses’ health study. J Nurs Manag. 2016;24(2):192–200. doi:10.1111/jonm.12298.Google Scholar

Park, JN, Han, MA, Park, J, Ryu, SY. Prevalence of depressive symptoms and related factors in Korean employees: The third Korean working conditions survey (2011). Int J Environ Res Public Health. 2016;13(4):424. doi:10.3390/ijerph13040424.Google Scholar

Deng, N, Kohn, TP, Lipshultz, LI, Pastuszak, AW. The relationship between shift work and men’s health. Sex Med Rev. 2018;6(3):446–456. doi:S2050-0521(17)30150-6.Google Scholar

Kohn, TP, Kohn, JR, Haney, NM, Pastuszak, AW, Lipshultz, LI. The effect of sleep on men’s health. Transl Androl Urol. 2020;9:S178–S185. doi:10.21037/tau.2019.11.07.Google Scholar

Feldman, HA, Irwin, G, Hatzichristou, DG, Krane, RJ, McKinlay, JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol. 1994;151(1):54–61. doi:10.1016/S0022-5347(17)34871-1.Google Scholar

Saigal, CS, Wessells, H, Pace, J, Schonlau, M, Wilt, TJ. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med. 2006;166(2):207–212. doi:10.1001/archinte.166.2.207.Google Scholar

American Academy of Sleep Medicine Taskforce. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22(5):667–689. doi:10.1093/sleep/22.5.667.Google Scholar

Margel, D, Cohen, M, Livne, PM, Pillar, G. Severe, but not mild, obstructive sleep apnea syndrome is associated with erectile dysfunction. Urology. 2004;63(3):545–549. doi:10.1016/j.urology.2003.10.016.Google Scholar

Heruti, R, Shochat, T, Tekes-Manova, D, Ashkenazi, I, Justo, D. Association between erectile dysfunction and sleep disorders measured by self-assessment questionnaires in adult men. J Sex Med. 2005;2(4):543–550. doi:10.1111/j.1743-6109.2005.00072.x.Google Scholar

Budweiser, S, Enderlein, S, Jörres, RA, et al. Sleep apnea is an independent correlate of erectile and sexual dysfunction. J Sex Med. 2009;6(11):3147–3157. doi:10.1111/j.1743-6109.2009.01372.x.Google Scholar

Teloken, PE, Smith, EB, Lodowsky, C, Freedom, T, Mulhall, JP. Defining association between sleep apnea syndrome and erectile dysfunction. Urology. 2006;67(5):1033–1037. doi:10.1016/j.urology.2005.11.040.Google Scholar

Zheng, W, Chen, X, Huang, J, et al. Blood oxygen accumulation distribution area index is associated with erectile dysfunction in patients with sleep apnea: results from a cross-sectional study. Sex Med. 2020;8(1):36–44. doi:10.1016/j.esxm.2019.11.001.Google Scholar

İrer, B, Çelikhisar, A, Çelikhisar, H, Bozkurt, O, Demir, Ö. Evaluation of sexual dysfunction, lower urinary tract symptoms and quality of life in men with obstructive sleep apnea syndrome and the efficacy of continuous positive airway pressure therapy. Urology. 2018;121:86–92. doi:10.1016/j.urology.2018.08.001.Google Scholar

Andersen, ML, Santos-Silva, R, Bittencourt, LRA, Tufik, S. Prevalence of erectile dysfunction complaints associated with sleep disturbances in Sao Paulo, Brazil: a population-based survey. Sleep Med. 2010;11(10):1019–1024. doi:10.1016/j.sleep.2009.08.016.Google Scholar

Kellesarian, SV, Malignaggi, VR, Feng, C, Javed, F. Association between obstructive sleep apnea and erectile dysfunction: a systematic review and meta-analysis. Int J Impot Res. 2018;30(3):129–140. doi:10.1038/s41443-018-0017-7.Google Scholar

Bozorgmehri, S, Fink, HA, Parimi, N, et al. Association of sleep disordered breathing with erectile dysfunction in community dwelling older men. J Urol. 2017;197(3):776–782. doi:10.1016/j.juro.2016.09.089.CrossRefGoogle ScholarPubMed

Seehuus, M, Pigeon, W. The sleep and sex survey: relationships between sexual function and sleep. J Psychosom Res. 2018;112:59–65. doi:10.1016/j.jpsychores.2018.07.005.Google Scholar

Le, HH, Salas, RME, Gamaldo, A, et al. The utility and feasibility of assessing sleep disruption in a men’s health clinic using a mobile health platform device: a pilot study. Int J Clin Pract. 2018;72(1):e12999. doi:10.1111/ijcp.12999.Google Scholar

Soterio-Pires, JH, Hirotsu, C, Kim, LJ, Bittencourt, L, Tufik, S, Andersen, ML. The interaction between erectile dysfunction complaints and depression in men: a cross-sectional study about sleep, hormones and quality of life. Int J Impot Res. 2017;29(2):70–75. doi:10.1038/ijir.2016.49.Google Scholar

Gao, X, Schwarzschild, MA, O’Reilly, EJ, Wang, H, Ascherio, A. Restless legs syndrome and erectile dysfunction. Sleep. 2010;33(1):75–79. doi:10.1093/sleep/33.1.75.Google Scholar

Li, Y, Batool-Anwar, S, Kim, S, Rimm, EB, Ascherio, A, Gao, X. Prospective study of restless legs syndrome and risk of erectile dysfunction. Am J Epidemiol. 2013;177(10):1097–1105. doi:10.1093/aje/kws364.Google Scholar

Pascual, M, Batlle, Jd, Barbé, F, et al. Erectile dysfunction in obstructive sleep apnea patients: a randomized trial on the effects of continuous positive airway pressure (CPAP). PLoS ONE. 2018;13(8):e0201930. doi:10.1371/journal.pone.0201930.Google Scholar

Jara, SM, Hopp, ML, Weaver, EM. Association of continuous positive airway pressure treatment with sexual quality of life in patients with sleep apnea: follow-up study of a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2018;144(7):587–593. doi:10.1001/jamaoto.2018.0485.Google Scholar

Melehan, KL, Hoyos, CM, Hamilton, GS, et al. Randomized trial of CPAP and vardenafil on erectile and arterial function in men with obstructive sleep apnea and erectile dysfunction. J Clin Endocrinol Metab. 2018;103(4):1601–1611. doi:10.1210/jc.2017-02389.Google Scholar

Pastore, AL, Palleschi, G, Ripoli, A, et al. Severe obstructive sleep apnoea syndrome and erectile dysfunction: a prospective randomised study to compare sildenafil vs. nasal continuous positive airway pressure. Int J Clin Pract. 2014;68(8):995–1000. doi:10.1111/ijcp.12463.Google Scholar

Li, Z, Fang, Z, Xing, N, Zhu, S, Fan, Y. The effect of CPAP and PDE5i on erectile function in men with obstructive sleep apnea and erectile dysfunction: a systematic review and meta-analysis. Sleep Med Rev. 2019;48:101217. doi:S1087-0792(19)30185-6.Google Scholar

Pastuszak, AW, Moon, YM, Scovell, J, et al. Poor sleep quality predicts hypogonadal symptoms and sexual dysfunction in male nonstandard shift workers. Urology. 2017;102:121–125. doi:10.1016/j.urology.2016.11.033.Google Scholar

Rodriguez, KM, Kohn, TP, Kohn, JR, et al. Pd27–06 shift work sleep disorder and night shift work significantly impair erectile function. J Urol. 2018;199(4):e559. doi:10.1016/j.juro.2018.02.1357.Google Scholar

Taylor, BC, Wilt, TJ, Fink, HA, et al. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006;68(4):804–809. doi.10.1016/j.urology.2006.04.019.Google Scholar

Lepor, H. Pathophysiology of lower urinary tract symptoms in the aging male population. Rev Urol. 2005;7(Suppl. 7):S3–S11. www.ncbi.nlm.nih.gov/pubmed/16986059.Google Scholar

Bates, J, Kohn, T, Rodriguez, K, et al. Pd65–08: poor sleep quality is associated with clinically significant lower urinary tract symptoms. J Urol. 2019;201:e1189–e1190. doi:10.1097/01.JU.0000557582.48673.b0.Google Scholar

Martin, SA, Appleton, SL, Adams, RJ, et al. Nocturia, other lower urinary tract symptoms and sleep dysfunction in a community-dwelling cohort of men. Urology. 2016;97:219–226. doi.org/10.1016/j.urology.2016.06.022.Google Scholar

Arslan, B, Gezmis, CT, Çetin, B, et al. Is obstructive sleep apnea syndrome related to nocturia? Low Urin Tract Symptoms. 2019;11(3):139–142. doi:10.1111/luts.12250.Google Scholar

Miyauchi, Y, Okazoe, H, Tamaki, M, et al. Obstructive sleep apnea syndrome as a potential cause of nocturia in younger adults. Urology. 2020;143:42–47. doi:10.1016/j.urology.2020.04.116.Google Scholar

Everaert, K, Anderson, P, Wood, R, Andersson, FL, Holm-Larsen, T. Nocturia is more bothersome than daytime LUTS: results from an observational, real-life practice database including 8659 European and American LUTS patients. Int J Clin Pract. 2018;72(6):e13091. doi:10.1111/ijcp.13091.Google Scholar

Doo, SW, Lee, HJ, Ahn, J, et al. Strong impact of nocturia on sleep quality in patients with lower urinary tract symptoms. World J Mens Health. 2012;30(2):123–130. doi:10.5534/wjmh.2012.30.2.123.Google Scholar

Obayashi, K, Saeki, K, Kurumatani, N. Quantitative association between nocturnal voiding frequency and objective sleep quality in the general elderly population: the HEIJO-KYO cohort. Sleep Medicine. 2015;16(5):577–582. doi:10.1016/j.sleep.2015.01.021.Google Scholar

Fantus, RJ, Packiam, VT, Wang, CH, Erickson, BA, Helfand, BT. The relationship between sleep disorders and lower urinary tract symptoms: results from the NHANES. J Urol. 2018;200(1):161–166. doi:10.1016/j.juro.2018.01.083.Google Scholar

Miyauchi, Y, Okazoe, H, Okujyo, M, et al. Effect of the continuous positive airway pressure on the nocturnal urine volume or night-time frequency in patients with obstructive sleep apnea syndrome. Urology. 2015;85(2):333–336. doi:10.1016/j.urology.2014.11.002.Google Scholar

Fernández-Pello, S, Gil, R, Escaf, S, et al. Síntomas de tramo urinario inferior y síndrome de apnea obstructiva del sueño: evolución urodinámica antes y después de un año de tratamiento con presión continua positiva de la vía aérea. Actas Urológicas Españolas. 2019;43(7):371–377. doi:10.1016/j.acuro.2019.03.004.Google Scholar

Park, HK, Paick, SH, Kim, HG, et al. Nocturia improvement with surgical correction of sleep apnea. Int Neurourol J. 2016;20(4):329–334. doi:10.5213/inj.1632624.312.Google Scholar

Shimizu, N, Nozawa, M, Sugimoto, K, et al. Therapeutic efficacy and anti-inflammatory effect of ramelteon in patients with insomnia associated with lower urinary tract symptoms. Res Rep Urol. 2013;5:113–119. doi:10.2147/RRU.S44502.Google Scholar

Takao, T, Tsujimura, A, Kiuchi, H, Takezawa, K, Nonomura, N, Miyagawa, Y. Improvement of nocturia and sleep disturbance by silodosin in male patients with lower urinary tract symptoms. Int J Urol. 2015;22(2):236–238. doi:10.1111/iju.12638.Google Scholar

Sakuma, T, Sato, K, Nagane, Y, et al. Effects of α1-blockers for lower urinary tract symptoms and sleep disorders in patients with benign prostatic hyperplasia. Lower Urin Tract Symptoms. 2010;2(2):119–122. doi:10.1111/j.1757-5672.2010.00073.x.Google Scholar

Kim, JW. Effect of shift work on nocturia. Urology. 2016;87:153–160. doi:10.1016/j.urology.2015.07.047.Google Scholar

Sigalos, JT, Kohn, TP, Cartagenova, L, et al. Shift workers with shift work disorder have worse lower urinary tract symptoms. Urology. 2019;128:66–70. doi:10.1016/j.urology.2019.02.025.Google Scholar

Scovell, JM, Pastuszak, AW, Slawin, J, Badal, J, Link, RE, Lipshultz, LI. Impaired sleep quality is associated with more significant lower urinary tract symptoms in male shift workers. Urology. 2017;99:197–202. doi:10.1016/j.urology.2016.05.076.Google Scholar

Branche, BL, Howard, LE, Moreira, DM, et al. Sleep problems are associated with development and progression of lower urinary tract symptoms: results from REDUCE. J Urol. 2018;199(2):536–542. doi:10.1016/j.juro.2017.08.108.Google Scholar

Araujo, AB, Yaggi, HK, Yang, M, McVary, KT, Fang, SC, Bliwise, DL. Sleep related problems and urological symptoms: testing the hypothesis of bidirectionality in a longitudinal, population based study. J Urol. 2014;191(1):100–106. doi:S0022-5347(13)04886-6.Google Scholar

Fukunaga, A, Kawaguchi, T, Funada, S, et al. Sleep disturbance worsens lower urinary tract symptoms: the Nagahama study. J Urol. 2019;202(2):354. doi:10.1097/JU.0000000000000212.Google Scholar

Mulhall, JP, Trost, LW, Brannigan, RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423–432. doi:S0022-5347(18)42817-0.Google Scholar

Evans, JI, MacLean, AW, Ismail, AA, Love, D. Concentrations of plasma testosterone in normal men during sleep. Nature. 1971;229(5282):261–262. doi:10.1038/229261a0.Google Scholar

Åkerstedt, T, Palmblad, J, de la Torre, B, Marana, R, Gillberg, M. Adrenocortical and gonadal steroids during sleep deprivation. Sleep. 1980;3(1):23–30. doi:10.1093/sleep/3.1.23.Google Scholar

Cortés-Gallegos, V, Castañeda, G, Alonso, R, et al. Sleep deprivation reduces circulating androgens in healthy men. Arch Androl. 1983;10(1):33–37. doi:10.3109/01485018308990167.Google Scholar

González-Santos, MR, Gajá-Rodríguez, OV, Alonso-Uriarte, R, Sojo-Aranda, I, Cortés-Gallegos, V. Sleep deprivation and adaptive hormonal responses of healthy men. Arch Androl. 1989;22(3):203–207. doi:10.3109/01485018908986773.Google Scholar

Leproult, R, Van Cauter, E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305(21):2173–2174. doi:10.1001/jama.2011.710.Google Scholar

Smith, I, Salazar, I, RoyChoudhury, A, St-Onge, MP. Sleep restriction and testosterone concentrations in young healthy males: randomized controlled studies of acute and chronic short sleep. Sleep Health. 2019;5(6):580–586. doi:S2352-7218(19)30139-1.Google Scholar

Jauch-Chara, K, Schmid, SM, Hallschmid, M, Oltmanns, KM, Schultes, B. Pituitary-gonadal and pituitary-thyroid axis hormone concentrations before and during a hypoglycemic clamp after sleep deprivation in healthy men. PLoS ONE. 2013;8(1):e54209. doi:10.1371/journal.pone.0054209.Google Scholar

Arnal, PJ, Drogou, C, Sauvet, F, et al. Effect of sleep extension on the subsequent testosterone, cortisol and prolactin responses to total sleep deprivation and recovery. J Neuroendocrinol. 2016;28(2). doi:10.1111/jne.12346.Google Scholar

Luboshitzky, R, Zabari, Z, Shen-Orr, Z, Herer, P, Lavie, P. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab. 2001;86(3):1134–1139. doi:10.1210/jcem.86.3.7296.Google Scholar

Reynolds, AC, Dorrian, J, Liu, PY, et al. Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men. PLoS ONE. 2012;7(7):e41218. doi:10.1371/journal.pone.0041218.Google Scholar

Schmid, SM, Hallschmid, M, Jauch-Chara, K, Lehnert, H, Schultes, B. Sleep timing may modulate the effect of sleep loss on testosterone. Clin Endocrinol (Oxf). 2012;77(5):749–754. doi:10.1111/j.1365-2265.2012.04419.x.Google Scholar

Patel, P, Shiff, B, Kohn, TP, Ramasamy, R. Impaired sleep is associated with low testosterone in US adult males: results from the National Health and Nutrition Examination Survey. World J Urol. 2019;37(7):1449–1453. doi:10.1007/s00345-018-2485-2.Google Scholar

Penev, PD. Association between sleep and morning testosterone levels in older men. Sleep. 2007;30(4):427–432. doi:10.1093/sleep/30.4.427.Google Scholar

Du, C, Yang, Y, Chen, J, Feng, L, Lin, W. Association between sleep quality and semen parameters and reproductive hormones: a cross-sectional study in Zhejiang, China. Nat Sci Sleep. 2020;12:11–18. doi:10.2147/NSS.S235136.Google Scholar

Mohammadi, H, Rezaei, M, Sharafkhaneh, A, Khazaie, H, Ghadami, MR. Serum testosterone/cortisol ratio in people with obstructive sleep apnea. J Clin Lab Anal. 2020;34(1):e23011. doi:10.1002/jcla.23011.Google Scholar

Mohammadi, H, Rezaei, M, Faghihi, F, Khazaie, H. Hypothalamic–pituitary–gonadal activity in paradoxical and psychophysiological insomnia. J Med Signals Sens. 2019;9(1):59–67. doi:10.4103/jmss.JMSS_31_18.Google Scholar

Auyeung, TW, Kwok, T, Leung, J, et al. Sleep duration and disturbances were associated with testosterone level, muscle mass, and muscle strength: a cross-sectional study in 1274 older men. J Am Med Dir Assoc. 2015;16(7):630.e1–630.e6. doi:S1525-8610(15)00294-7.Google Scholar

Brigette, MC, Andrew, DV, Martin, S, et al. Obstructive sleep apnea is not an independent determinant of testosterone in men. Eur J Endocrinol. 2020;183(1):31–39. doi:10.1530/EJE-19-0978.Google Scholar

Wittert, G. The relationship between sleep disorders and testosterone in men. Asian J Androl. 2014;16(2):262–265. doi:10.4103/1008-682X.122586.CrossRefGoogle ScholarPubMed

Touitou, Y, Motohashi, Y, Reinberg, A, et al. Effect of shift work on the night-time secretory patterns of melatonin, prolactin, cortisol and testosterone. Eur J Appl Physiol Occup Physiol. 1990;60(4):288–292. doi:10.1007/BF00379398.Google Scholar

Axelsson, J, Åkerstedt, T, Kecklund, G, Lindqvist, A, Attefors, R. Hormonal changes in satisfied and dissatisfied shift workers across a shift cycle. J Appl Physiol. 2003;95(5):2099–2105. doi:10.1152/japplphysiol.00231.2003.Google Scholar

Smith, AM, Morris, P, Rowell, KO, Clarke, S, Jones, TH, Channer, KS. Junior doctors and the full shift rota – psychological and hormonal changes: a comparative cross-sectional study. Clin Med. 2006;6(2):174–177. doi:10.7861/clinmedicine.6-2-174.Google Scholar

Jensen, MA, Hansen, ÅM, Kristiansen, J, Nabe-Nielsen, K, Garde, AH. Changes in the diurnal rhythms of cortisol, melatonin, and testosterone after 2, 4, and 7 consecutive night shifts in male police officers. Chronobiol Int. 2016;33(9):1280–1292. doi:10.1080/07420528.2016.1212869.Google Scholar

Charlier, CM, Barr, ML, Colby, SE, Greene, GW, Olfert, MD. Correlations of self-reported androgen deficiency in ageing males (ADAM) with stress and sleep among young adult males. Healthcare (Basel, Switzerland). 2018;6(4):121. doi:10.3390/healthcare6040121.Google Scholar

Balasubramanian, A, Kohn, TP, Santiago, JE, et al. Increased risk of hypogonadal symptoms in shift workers with shift work sleep disorder. Urology. 2020;138:52–59. doi:10.1016/j.urology.2019.10.040.Google Scholar

Morley, JE, Charlton, E, Patrick, P, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism. 2000;49(9):1239–1242. doi:S0026-0495(00)25964-7.Google Scholar

Jarow, JP, Sharlip, ID, Belker, AM, et al. Best practice policies for male infertility. J Urol. 2002;167(5):2138–2144. doi:S0022-5347(05)65109-9.Google Scholar

Wise, LA, Rothman, KJ, Wesselink, AK, et al. Male sleep duration and fecundability in a North American preconception cohort study. Fertil Steril. 2018;109(3):453–459. doi:10.1016/j.fertnstert.2017.11.037.Google Scholar

Kohn, TP, Pastuszak, A. Shift work is associated with altered semen parameters in infertile men. Fertil Steril. 2017;108(3):E323–E324. doi:10.1016/j.fertnstert.2017.07.956.Google Scholar

Jensen, TK, Andersson, A, Skakkebæk, NE, et al. Association of sleep disturbances with reduced semen quality: a cross-sectional study among 953 healthy young Danish men. Am J Epidemiol. 2013;177(10):1027–1037. doi:10.1093/aje/kws420.Google Scholar

Chen, Q, Yang, H, Zhou, N, et al. Inverse U-shaped association between sleep duration and semen quality: longitudinal observational study (MARHCS) in Chongqing, China. Sleep. 2016;39(1):79–86. doi:10.5665/sleep.5322.Google Scholar

Wang, X, Chen, Q, Zou, P, et al. Sleep duration is associated with sperm chromatin integrity among young men in Chongqing, China. J Sleep Res. 2018;27(4):e12615. doi:10.1111/jsr.12615.Google Scholar

Hvidt, JEM, Knudsen, UB, Zachariae, R, Ingerslev, HJ, Philipsen, MT, Frederiksen, Y. Associations of bedtime, sleep duration, and sleep quality with semen quality in males seeking fertility treatment: a preliminary study. Basic Clin Androl. 2020;30:5–7. doi:10.1186/s12610-020-00103-7.Google Scholar